1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Chronic Disease Market Trends
  5. > Extracorporeal Membrane Oxygenation Systems Market by Modality, Veno -Venous, Arterio-Venous, by Application, by Geography - Global Forecast to 2020

The global extracorporeal membrane oxygenation (ECMO) system market accounted for USD 227.7 million in 2014 and is expected to reach USD 287.6 million by 2020 at a CAGR of 4.0% from 2015 to 2020.

The purpose of this report is to cover the definition, description, and forecast of Global Extracorporeal Membrane Oxygenation (ECMO) System market. It involves deep dive analysis of market segmentation which comprises of submarkets, modality and application. The report also offers strategic analysis of key players in the market. In this report, the Extracorporeal Membrane Oxygenation (ECMO) System market is segmented on the basis of its modality and application. In terms of modality, the market is segmented into Veno Artrial (VA), Veno Venous (VV), Artrio Venous (ECOO2 R).

This market has been segmented by application, which includes Respiratory, Cardiac, and Extra-Corporeal Cardiopulmonary Resuscitation (ECPR). The respiratory segment was the largest application of the global Extracorporeal Membrane Oxygenation (ECMO) System market in 2014.

Globally, North America contributed to the largest Extracorporeal Membrane Oxygenation (ECMO) System market in 2014. The large share is attributed to rise in the increasing number of patients suffering from respiratory failure and cardiopulmonary disease, rising incidence in Chronic Obtrusive Pulmonary Diseases (COPD), increasing adoption rate of ECMO machine in hospitals, technological advancements in ECMO system, success rate of ECMO and government initiatives and growing awareness towards ECMO. All these factors would help improve the demand of ECMO machines, which are used on a small scale in hospitals currently.

Furthermore, increasing number of patients suffering from respiratory failure and cardiopulmonary disease are other growth factors. With the rising number of cases globally, there is a boost in the growth of extra corporeal membrane oxygenators market. Respiratory failure may affect the muscles, nerves, bones, or tissues that support breathing, or they may affect the lungs directly. Over 3 million Canadians of all ages have a serious respiratory disease such as asthma, chronic obstructive pulmonary disease (COPD), lung cancer, tuberculosis (TB), cystic fibrosis, and respiratory distress syndrome. More than 5 million patients are admitted annually to ICUs in the U.S. In 2010, cardiovascular, lung, and blood diseases accounted for 1,017,000 deaths and 41 percent of all deaths in the U.S. However, cost of high end equipment, presence of conventional techniques, risk of complications, renal failure associated with ECMO are some of the restraints for the Extracorporeal Membrane Oxygenation (ECMO) System market.

The report also provides a detailed competitive landscaping of companies operating in this market. It also offers segment and country specific company shares, news & deals, M&A, segment specific pipeline products, product approvals and product recalls of major companies. The main companies operating in this market are MAQUET Holding B.V. & CO. KG. (Germany), SORIN Group (Italy), MEDTRONIC (Republic of Ireland), NIPRO Medical Corporation (U.S.), Terumo Medical Corporation (Japan), MicroPort Scientific Corporation (China), Medos Medizintechnik AG (Germany).


Reasons to Buy the Report:

From an insight perspective, this research report has focused on various levels of analysis, namely, industry analysis (industry trends and PEST analysis), market share analysis of top players, supply chain analysis, and company profiles. Also, the report covers basic views on the competitive landscape, usage patterns, emerging- and high-growth segments, high-growth regions and countries and their respective regulatory policies, government initiatives, drivers, restraints, and opportunities in the Extracorporeal Membrane Oxygenation (ECMO) System market.

The report offers detailed information on new entrants/smaller firms to gauge the pulse of the market, which in turn helps garner the market share. The firms purchasing the report could use any one or a combination of the below mentioned five strategies to strengthen their market share.

The report provides insights on the following pointers:

- Product Analysis and Development: Detailed insights on upcoming technologies, research and development activities, and new product launches in the market.
- Market Development: Offers comprehensive information about lucrative emerging markets. Analysis of market across various regions; distribution channels, clientele base and pricing policies involved vis-à-vis geographies.
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments decisions. Detailed description regarding the related and unrelated diversification pertaining to the market.
- Competitive Assessment: An in-depth assessment of market shares and company share analyses of the key players projected till 2020. Business strategies and manufacturing capabilities of leading players are also provided.

Table Of Contents

Extracorporeal Membrane Oxygenation Systems Market by Modality, Veno -Venous, Arterio-Venous, by Application, by Geography - Global Forecast to 2020
TABLE OF CONTENTS

1 INTRODUCTION 16
1.1 OBJECTIVES OF THE STUDY 16
1.2 MARKET SEGMENTATION and COVERAGE 17
1.3 STAKEHOLDERS 18
2 RESEARCH METHODOLOGY 19
2.1 INTEGRATED ECOSYSTEM OF THE EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET 20
2.2 ARRIVING AT THE EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET SIZE 21
2.2.1 TOP-DOWN APPROACH 22
2.2.2 MACRO INDICATOR- BASED APPROACH 23
2.3 PRICE ANALYSIS OF EXTRA CORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY PRODUCT 24
2.4 ASSUMPTIONS 24
3 EXECUTIVE SUMMARY 25
4 MARKET OVERVIEW 28
4.1 MARKET DRIVERS AND INHIBITORS 28
4.2 THREATS OF ECMO 30
4.3 OPPORTUNITIES IN FUTURE 31
5 EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET,
BY MODALITY 32
5.1 INTRODUCTION 33
5.2 VENO-ARTERIAL 34
5.3 VENO-VENOUS 35
5.4 ARTERIO-VENOUS (AV) 36
6 EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET,
BY APPLICATION 38
6.1 INTRODUCTION 39
6.2 RESPIRATORY 41
6.2.1 NEONATES 42
6.2.2 PEDIATRIC 43
6.2.3 ADULT 43

6.3 CARDIAC 43
6.3.1 NEONATES 44
6.3.2 PEDIATRIC 44
6.3.3 ADULT 44
6.4 EXTRACORPOREAL CARDIOPULMONARY RESUSCITATION (ECPR) 45
6.4.1 NEONATES 46
6.4.2 PEDIATRIC 46
6.4.3 ADULT 46
7 EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET,
BY GEOGRAPHY 47
7.1 INTRODUCTION 48
7.2 NORTH AMERICA 49
7.2.1 U.S. 53
7.2.2 CANADA 56
7.2.3 MEXICO 59
7.3 EUROPE 62
7.3.1 GERMANY 67
7.3.2 U.K. 69
7.3.3 FRANCE 72
7.3.4 ITALY 74
7.3.5 SPAIN 77
7.3.6 SWITZERLAND 79
7.3.7 REST OF EUROPE (ROE) 82
7.4 ASIA-PACIFIC (APAC) 85
7.4.1 JAPAN 90
7.4.2 AUSTRALIA 93
7.4.3 CHINA 96
7.4.4 INDIA 99
7.4.5 SINGAPORE 102
7.4.6 REPUBLIC OF KOREA 104
7.4.7 REST OF ASIA-PACIFIC 107
7.5 REST OF THE WORLD (ROW) 109
8 COMPETITIVE LANDSCAPE 113
8.1.1 NEW PRODUCT LAUNCH and PRODUCT DEVELOPMENT 114
8.1.2 AGREEMENT, ACQUISITION and PARTNERSHIP 115
8.1.3 EXPANSION 116
8.1.4 OTHER 117

9 COMPANY PROFILES 118
9.1 MAQUET HOLDING B.V. and CO. KG. 118
9.1.1 OVERVIEW 118
9.1.2 KEY FINANCIALS 118
9.1.3 PRODUCT AND SERVICE OFFERINGS 119
9.1.4 RELATED DEVELOPMENTS 120
9.1.5 MNM VIEW 121
9.2 MEDTRONIC, INC. (U.S.) 122
9.2.1 OVERVIEW 122
9.2.2 KEY FINANCIALS 122
9.2.3 PRODUCT AND SERVICE OFFERINGS 123
9.2.4 RELATED DEVELOPMENTS 124
9.2.5 MNM VIEW 124
9.3 MICROPORT SCIENTIFIC CORPORATION 125
9.3.1 OVERVIEW 125
9.3.2 KEY FINANCIALS 125
9.3.3 PRODUCT AND SERVICE OFFERINGS 126
9.3.4 MNM VIEW 126
9.4 TERUMO CARDIOVASCULAR SYSTEMS CORPORATION 127
9.4.1 OVERVIEW 127
9.4.2 KEY FINANCIALS 127
9.4.3 PRODUCT AND SERVICE OFFERINGS 128
9.4.4 RELATED DEVELOPMENTS 128
9.4.5 MNM VIEW 128
9.5 MEDOS MEDIZINTECHNIK AG 129
9.5.1 OVERVIEW 129
9.5.2 PRODUCT AND SERVICE OFFERINGS 129
9.5.3 RELATED DEVELOPMENTS 130
9.5.4 MNM VIEW 130
9.6 NIPRO MEDICAL CORPORATION 131
9.6.1 OVERVIEW 131
9.6.2 KEY FINANCIALS 131
9.6.3 PRODUCT AND SERVICE OFFERINGS 131
9.6.4 RELATED DEVELOPMENTS 132
9.6.5 MNM VIEW 132
9.7 SORIN GROUP (SORIN S.P.A.) 133
9.7.1 OVERVIEW 133
9.7.2 SORIN GROUP: KEY FINANCIALS 133
9.7.3 PRODUCT AND SERVICE OFFERINGS 134
9.7.4 RELATED DEVELOPMENTS 135
9.7.5 MNM VIEW 135
10 APPENDIX 136
10.1 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 136
10.2 CUSTOMIZATION OPTIONS 137
10.2.1 PRODUCT ANALYSIS 137
10.2.2 PULMONOLOGIST/PHYSICIANS PERCEPTION ANALYSIS 137
10.2.3 REGULATORY FRAMEWORK 137
10.2.4 COMPETITIVE INTELLIGENCE 137
10.3 RELATED REPORTS 138


LIST OF TABLES

TABLE 1 EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET: MACRO INDICATORS, BY COUNTRY, 2014 (USD MILLION) 23
TABLE 2 EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET: DRIVERS AND INHIBITORS 28
TABLE 3 EXTRACORPOREAL MEMBRANE OXYGENATION (ECMO) MARKET, BY MODALITY, 2013-2020 (USD MILLION) 33
TABLE 4 VENO-ARTERIAL EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY GEOGRAPHY, 2013-2020 (USD MILLION) 34
TABLE 5 VENO-VENOUS EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY GEOGRAPHY, 2013-2020 (USD MILLION) 36
TABLE 6 ARTERIO-VENOUS EXTRACORPOREAL MEMBRANE OXYGENATION MARKET,
BY GEOGRAPHY, 2013-2020 (USD MILLION) 37
TABLE 7 EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET,
BY APPLICATION, 2013-2020 (USD MILLION) 40
TABLE 8 EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET IN RESPIRATORY APPLICATION, BY AGE GROUP, 2013-2020 (USD MILLION) 41
TABLE 9 EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET IN CARDIAC APPLICATION, BY AGE GROUP, 2013-2020 (USD MILLION) 44
TABLE 10 EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET IN ECPR,
BY AGE GROUP, 2013-2020 (USD MILLION) 45
TABLE 11 EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET,
BY GEOGRAPHY, 2013-2020 (USD MILLION) 48
TABLE 12 NORTH AMERICA: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY MODALITY, 2013-2020 (USD MILLION) 50
TABLE 13 NORTH AMERICA: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY APPLICATION, 2013-2020 (USD MILLION) 51
TABLE 14 NORTH AMERICA: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET IN RESPIRATORY APPLICATION, BY AGE GROUP, 2013-2020 (USD MILLION) 51
TABLE 15 NORTH AMERICA: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET IN CARDIAC APPLICATION, BY AGE GROUP, 2013-2020 (USD MILLION) 52
TABLE 16 NORTH AMERICA: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET IN ECPR APPLICATION, BY AGE GROUP, 2013-2020 (USD MILLION) 53
TABLE 17 U.S.: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET,
BY MODALITY, 2013-2020 (USD MILLION) 55
TABLE 18 U.S.: EXTRA CORPOREAL MEMBRANE OXYGENATION MARKET, BY APPLICATION, 2013-2020 (USD MILLION) 55
TABLE 19 CANADA: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET,
BY MODALITY, 2013-2020 (USD MILLION) 57
TABLE 20 CANADA: EXTRACORPOREAL MEMBRANE OXYGENATION MARKET,
BY APPLICATION, 2013-2020 (USD MILLION) 58
TABLE 21 MEXICO: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET,
BY MODALITY, 2013-2020 (USD MILLION) 60
TABLE 22 MEXICO: EXTRACORPOREAL MEMBRANE OXYGENATION MARKET, BY APPLICATION, 2013-2020 (USD MILLION) 61
TABLE 23 EUROPE: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET,
BY MODALITY, 2013-2020 (USD MILLION) 63
TABLE 24 EUROPE: EXTRACORPOREAL MEMBRANE OXYGENATION MARKET,
BY APPLICATION, 2013-2020 (USD MILLION) 63
TABLE 25 EUROPE: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET IN RESPIRATORY APPLICATION, BY AGE GROUP, 2013-2020 (USD MILLION) 64
TABLE 26 EUROPE: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET IN CARDIAC APPLICATION, BY AGE GROUP, 2013-2020 (USD MILLION) 65
TABLE 27 EUROPE: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET IN ECPR APPLICATION, BY AGE GROUP, 2013-2020 (USD MILLION) 66
TABLE 28 GERMANY: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET,
BY MODALITY, 2013-2020 (USD MILLION) 68
TABLE 29 GERMANY: EXTRACORPOREAL MEMBRANE OXYGENATION MARKET,
BY APPLICATION, 2013-2020 (USD MILLION) 68
TABLE 30 U.K.: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET,
BY MODALITY, 2013-2020 (USD MILLION) 71
TABLE 31 U.K.: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET,
BY APPLICATION, 2013-2020 (USD MILLION) 71
TABLE 32 FRANCE: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET,
BY MODALITY, 2013-2020 (USD MILLION) 73
TABLE 33 FRANCE: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET,
BY APPLICATION, 2013-2020 (USD MILLION) 73
TABLE 34 ITALY: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET,
BY MODALITY, 2013-2020 (USD MILLION) 75
TABLE 35 ITALY: EXTRACORPOREAL MEMBRANE OXYGENATION MARKET, BY APPLICATION, 2013-2020 (USD MILLION) 76
TABLE 36 SPAIN: EXTRA CORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET,
BY MODALITY, 2013-2020 (USD MILLION) 78
TABLE 37 SPAIN: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET,
BY APPLICATION, 2013-2020 (USD MILLION) 78
TABLE 38 SWITZERLAND: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY MODALITY, 2013-2020 (USD MILLION) 80
TABLE 39 SWITZERLAND: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY APPLICATION, 2013-2020 (USD MILLION) 81
TABLE 40 ROE: EXTRA CORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET,
BY MODALITY, 2013-2020 (USD MILLION) 83
TABLE 41 ROE: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET,
BY APPLICATION, 2013-2020 (USD MILLION) 84
TABLE 42 APAC: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET,
BY MODALITY, 2013-2020 (USD MILLION) 86
TABLE 43 APAC: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET,
BY APPLICATION, 2013-2020 (USD MILLION) 86
TABLE 44 APAC: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET IN RESPIRATORY APPLICATION, BY AGE GROUP, 2013-2020 (USD MILLION) 87
TABLE 45 APAC: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET IN CARDIAC APPLICATION, BY AGE GROUP, 2013-2020 (USD MILLION) 88
TABLE 46 APAC: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET IN ECPR APPLICATION, BY AGE GROUP, 2013-2020 (USD MILLION) 89
TABLE 47 JAPAN: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET,
BY MODALITY, 2013-2020 (USD MILLION) 91
TABLE 48 JAPAN: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET,
BY APPLICATION, 2013-2020 (USD MILLION) 92
TABLE 49 AUSTRALIA: EXTRA CORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET,
BY MODALITY, 2013-2020 (USD MILLION) 94
TABLE 50 AUSTRALIA: EXTRA CORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET,
BY APPLICATION, 2013-2020 (USD MILLION) 95
TABLE 51 CHINA: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET,
BY MODALITY, 2013-2020 (USD MILLION) 97
TABLE 52 CHINA: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET,
BY APPLICATION, 2013-2020 (USD MILLION) 98
TABLE 53 INDIA: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET,
BY MODALITY, 2013-2020 (USD MILLION) 100
TABLE 54 INDIA: EXTRA CORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET,
BY APPLICATION, 2013-2020 (USD MILLION) 101
TABLE 55 SINGAPORE: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET,
BY MODALITY, 2013-2020 (USD MILLION) 103
TABLE 56 SINGAPORE: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET,
BY APPLICATION, 2013-2020 (USD MILLION) 103
TABLE 57 REPUBLIC OF KOREA: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY MODALITY, 2013-2020 (USD MILLION) 105
TABLE 58 REPUBLIC OF KOREA: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY APPLICATION, 2013-2020 (USD MILLION) 106
TABLE 59 REST OF APAC: EXTRA CORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY MODALITY, 2013-2020 (USD MILLION) 108
TABLE 60 REST OF APAC: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY APPLICATION, 2013-2020 (USD MILLION) 108
TABLE 61 ROW: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET,
BY MODALITY, 2013-2020 (USD MILLION) 109
TABLE 62 ROW: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET,
BY APPLICATION, 2013-2020 (USD MILLION) 110
TABLE 63 ROW: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET IN RESPIRATORY APPLICATION, BY AGE GROUP, 2013-2020 (USD MILLION) 111
TABLE 64 ROW: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET IN CARDIAC APPLICATION, BY AGE GROUP, 2013-2020 (USD MILLION) 111
TABLE 65 ROW: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET IN ECPR APPLICATION, BY AGE GROUP, 2013-2020 (USD MILLION) 112
TABLE 66 EXTRA CORPOREAL MEMBRANE OXYGENATION SYSTEM MARKET, BY COMPANY, 2014 (%) 113
TABLE 67 MAQUET HOLDING B.V. and CO. KG.: KEY FINANCIALS, BY BUSINESS SEGMENT, 2012-2014 (USD MN) 118
TABLE 68 MAQUET HOLDING B.V. and CO. KG.: KEY FINANCIALS, BY GEOGRAPHY,
2012-2014 (USD MN) 119
TABLE 69 MEDTRONIC, INC. : KEY FINANCIALS, BY BUSINESS SEGMENT,
2012-2014 (USD MN) 122
TABLE 70 MEDTRONIC, INC.: KEY FINANCIALS, BY GEOGRAPHY, 2012-2014 (USD MN) 123
TABLE 71 MICROPORT SCIENTIFIC CORPORATION: KEY FINANCIALS, BY BUSINESS SEGMENT, 2012-2014 (USD MN) 126
TABLE 72 MICROPORT SCIENTIFIC CORPORATION: KEY FINANCIALS, BY GEOGRAPHY,
2012-2014 (USD MN) 126
TABLE 73 TERUMO CARDIOVASCULAR SYSTEMS CORPORATION: KEY FINANCIALS,
BY BUSINESS SEGMENT, 2012-2014 (USD MN) 127
TABLE 74 TERUMO CARDIOVASCULAR SYSTEMS CORPORATION: KEY FINANCIALS,
BY GEOGRAPHY, 2012-2014 (USD MN) 128
TABLE 75 NIPRO MEDICAL CORPORATION: KEY FINANCIALS, BY BUSINESS SEGMENT,
2011-2014 (USD MN) 131
TABLE 76 SORIN GROUP: KEY FINANCIALS, BY BUSINESS SEGMENT, 2013-2014 (USD MN) 133
TABLE 77 SORIN GROUP: KEY FINANCIALS (CARDIAC SURGERY), BY BUSINESS SUB-SEGMENT, 2013-2014 (USD MN) 134
TABLE 78 SORIN GROUP: KEY FINANCIALS, BY GEOGRAPHY, 2013-2014 (USD MN) 134


LIST OF FIGURES

FIGURE 1 EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET SEGMENTATION and COVERAGE 17
FIGURE 2 EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET: INTEGRATED ECOSYSTEM 20
FIGURE 3 ARRIVING AT THE EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET SIZE 21
FIGURE 4 TOP-DOWN APPROACH 22
FIGURE 5 MACRO INDICATOR-BASED APPROACH 23
FIGURE 6 EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET SNAPSHOT 27
FIGURE 7 EXTRACORPOREAL MEMBRANE OXYGENATION MARKET, BY MODALITY,
2014 and 2020 (USD MILLION) 33
FIGURE 8 VENO-ARTERIAL EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY GEOGRAPHY, 2015 and 2020 (USD MILLION) 34
FIGURE 9 VENO-VENOUS EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY GEOGRAPHY, 2015 and 2020 (USD MILLION) 35
FIGURE 10 ARTERIO-VENOUS EXTRACORPOREAL MEMBRANE OXYGENATION MARKET,
BY GEOGRAPHY, 2015 and 2020 (USD MILLION) 37
FIGURE 11 INDICATIONS WHERE ECMO IS USED 39
FIGURE 12 EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET,
BY APPLICATION, 2014 and 2020 (USD MILLION) 40
FIGURE 13 EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET IN RESPIRATORY APPLICATION, BY AGE GROUP, 2015 and 2020 (USD MILLION) 41
FIGURE 14 NEONATAL SURVIVAL RATE, EXTRACORPOREAL LIFE SUPPORT ORGANIZATION (ELSO) DATA (1987-1993) 42
FIGURE 15 EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET IN CARDIAC APPLICATION, BY AGE GROUP, 2015 and 2020 (USD MILLION) 43
FIGURE 16 EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET IN ECPR,
BY AGE GROUP, 2015 and 2020 (USD MILLION) 45
FIGURE 17 EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO): GROWTH ANALYSIS,
BY GEOGRAPHY, 2014-2020 (USD MILLION) 48
FIGURE 18 NORTH AMERICA: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET OVERVIEW, 2014 and 2020 (%) 50
FIGURE 19 NORTH AMERICA: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET IN RESPIRATORY APPLICATION, BY AGE GROUP,
2015 and 2020 (USD MILLION) 51
FIGURE 20 NORTH AMERICA: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET IN CARDIAC APPLICATION, BY AGE GROUP, 2015 and 2020 (USD MILLION) 52
FIGURE 21 NORTH AMERICA: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET IN ECPR APPLICATION, BY AGE GROUP, 2015 and 2020 (USD MILLION) 53
FIGURE 22 U.S.: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET OVERVIEW, 2014 and 2020 (%) 54
FIGURE 23 U.S.: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET,
BY MODALITY, 2015 and 2020 (USD MILLION) 54
FIGURE 24 U.S.: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET,
BY APPLICATION, 2015 and 2020 (USD MILLION) 55
FIGURE 25 CANADA: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET OVERVIEW, 2014 and 2020 (%) 56
FIGURE 26 CANADA: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET,
BY MODALITY, 2015 and 2020 (USD MILLION) 57
FIGURE 27 CANADA: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET,
BY APPLICATION, 2015 and 2020 (USD MILLION) 58
FIGURE 28 MEXICO: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET OVERVIEW, 2014 and 2020 (%) 59
FIGURE 29 MEXICO: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET,
BY MODALITY, 2015 and 2020 (USD MILLION) 60
FIGURE 30 MEXICO: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET,
BY APPLICATION, 2015 and 2020 (USD MILLION) 61
FIGURE 31 EUROPE: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET OVERVIEW, 2014 and 2020 (%) 62
FIGURE 32 EUROPE: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET IN RESPIRATORY APPLICATION, BY AGE GROUP, 2015 and 2020 (USD MILLION) 64
FIGURE 33 EUROPE: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET IN CARDIAC APPLICATION, BY AGE GROUP, 2015 and 2020 (USD MILLION) 65
FIGURE 34 EUROPE: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET IN ECPR APPLICATION, BY AGE GROUP, 2015 and 2020 (USD MILLION) 66
FIGURE 35 GERMANY: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET OVERVIEW, 2014 and 2020 (%) 67
FIGURE 36 GERMANY: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET,
BY MODALITY, 2015 and 2020 (USD MILLION) 67
FIGURE 37 GERMANY: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET,
BY APPLICATION, 2015 and 2020 (USD MILLION) 68
FIGURE 38 U.K.: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET OVERVIEW, 2014 and 2020 (%) 70
FIGURE 39 U.K.: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET,
BY MODALITY, 2015 and 2020 (USD MILLION) 70
FIGURE 40 U.K.: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET,
BY APPLICATION, 2015 and 2020 (USD MILLION) 71
FIGURE 41 FRANCE: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET OVERVIEW, 2014 and 2020 (%) 72
FIGURE 42 FRANCE: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET,
BY MODALITY, 2015 and 2020 (USD MILLION) 72
FIGURE 43 FRANCE: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET,
BY APPLICATION, 2015 and 2020 (USD MILLION) 73
FIGURE 44 ITALY: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET OVERVIEW, 2014 and 2020 (%) 74
FIGURE 45 ITALY: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET,
BY MODALITY, 2015 and 2020 (USD MILLION) 75
FIGURE 46 ITALY: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET,
BY APPLICATION, 2015 and 2020 (USD MILLION) 76
FIGURE 47 SPAIN: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET OVERVIEW, 2014 and 2020 (%) 77
FIGURE 48 SPAIN: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET,
BY MODALITY, 2015 and 2020 (USD MILLION) 77
FIGURE 49 SPAIN: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET,
BY APPLICATION, 2015 and 2020 (USD MILLION) 78
FIGURE 50 SWITZERLAND: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET OVERVIEW, 2014 and 2020 (%) 79
FIGURE 51 SWITZERLAND: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY MODALITY, 2015 and 2020 (USD MILLION) 80
FIGURE 52 SWITZERLAND: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY APPLICATION, 2015 and 2020 (USD MILLION) 81
FIGURE 53 ROE: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET OVERVIEW, 2014 and 2020 (%) 82
FIGURE 54 ROE: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET,
BY MODALITY, 2015 and 2020 (USD MILLION) 83
FIGURE 55 ROE: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET,
BY APPLICATION, 2015 and 2020 (USD MILLION) 84
FIGURE 56 APAC: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET OVERVIEW, 2014 and 2020 (%) 85
FIGURE 57 APAC: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET IN RESPIRATORY APPLICATION, BY AGE GROUP, 2015 and 2020 (USD MILLION) 87
FIGURE 58 APAC: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET IN CARDIAC APPLICATION, BY AGE GROUP, 2015 and 2020 (USD MILLION) 88
FIGURE 59 APAC: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET IN ECPR APPLICATION, BY AGE GROUP, 2015 and 2020 (USD MILLION) 89
FIGURE 60 JAPAN: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET OVERVIEW, 2014 and 2020 (%) 90
FIGURE 61 JAPAN: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET,
BY MODALITY, 2015 and 2020 (USD MILLION) 91
FIGURE 62 JAPAN: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET,
BY APPLICATION, 2015 and 2020 (USD MILLION) 92
FIGURE 63 AUSTRALIA: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET OVERVIEW, 2014 and 2020 (%) 93
FIGURE 64 AUSTRALIA: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET,
BY MODALITY, 2015 and 2020 (USD MILLION) 94
FIGURE 65 AUSTRALIA: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET,
BY APPLICATION, 2015 and 2020 (USD MILLION) 95
FIGURE 66 CHINA: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET OVERVIEW, 2014 and 2020 (%) 96
FIGURE 67 CHINA: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET,
BY MODALITY, 2015 and 2020 (USD MILLION) 97
FIGURE 68 CHINA: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET,
BY APPLICATION, 2015 and 2020 (USD MILLION) 98
FIGURE 69 INDIA: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET OVERVIEW, 2014 and 2020 (%) 99
FIGURE 70 INDIA: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET,
BY MODALITY, 2015 and 2020 (USD MILLION) 100
FIGURE 71 INDIA: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET,
BY APPLICATION, 2015 and 2020 (USD MILLION) 101
FIGURE 72 SINGAPORE: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET OVERVIEW, 2014 and 2020 (%) 102
FIGURE 73 SINGAPORE: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET,
BY MODALITY, 2015 and 2020 (USD MILLION) 102
FIGURE 74 SINGAPORE: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET,
BY APPLICATION, 2015 and 2020 (USD MILLION) 103
FIGURE 75 REPUBLIC OF KOREA: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET OVERVIEW, 2014 and 2020 (%) 104
FIGURE 76 REPUBLIC OF KOREA: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY MODALITY, 2015 and 2020 (USD MILLION) 105
FIGURE 77 REPUBLIC OF KOREA: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY APPLICATION, 2015 and 2020 (USD MILLION) 106
FIGURE 78 REST OF APAC: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET OVERVIEW, 2014 and 2020 (%) 107
FIGURE 79 REST OF APAC: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY MODALITY, 2015 and 2020 (USD MILLION) 107
FIGURE 80 REST OF APAC: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET, BY APPLICATION, 2015 and 2020 (USD MILLION) 108
FIGURE 81 ROW: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET OVERVIEW, 2014 and 2020 (%) 109
FIGURE 82 ROW: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET IN RESPIRATORY APPLICATION, BY AGE GROUP, 2015 and 2020 (USD MILLION) 110
FIGURE 83 ROW: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET IN CARDIAC APPLICATION, BY AGE GROUP, 2015 and 2020 (USD MILLION) 111
FIGURE 84 ROW: EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEMS MARKET IN ECPR APPLICATION, BY AGE GROUP, 2015 and 2020 (USD MILLION) 112
FIGURE 85 EXTRACORPOREAL MEMBRANE OXYGENATION SYSTEM MARKET, BY COMPANY, 2014 (%) 113
FIGURE 86 MAQUET HOLDING B.V. and CO. KG.: REVENUE MIX, 2014 (%) 118
FIGURE 87 MEDTRONIC, INC.: REVENUE MIX, 2014 (%) 122
FIGURE 88 MICROPORT SCIENTIFIC CORPORATION: REVENUE MIX, 2014 (%) 125
FIGURE 89 TERUMO CORPORATION: REVENUE MIX, 2014 (%) 127
FIGURE 90 NIPRO MEDICAL CORPORATION: REVENUE MIX, 2014 (%) 131
FIGURE 91 SORIN GROUP: REVENUE MIX, 2014 (%) 133

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Frontier Pharma: Rheumatoid Arthritis - Cytokine Mediators and Kinase Inhibitors Dominate First-in-Class Product Innovation

Frontier Pharma: Rheumatoid Arthritis - Cytokine Mediators and Kinase Inhibitors Dominate First-in-Class Product Innovation

  • $ 6995
  • Industry report
  • August 2016
  • by GBI Research

Frontier Pharma: Rheumatoid Arthritis - Cytokine Mediators and Kinase Inhibitors Dominate First-in-Class Product Innovation Summary Rheumatoid Arthritis (RA) is a chronic, progressive and currently incurable ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...

Global Markets for Diabetes Therapeutics and Diagnostics

Global Markets for Diabetes Therapeutics and Diagnostics

  • $ 6650
  • Industry report
  • September 2016
  • by BCC Research

Use this report to: - Analyze the market for drugs used in the treatment of diabetes, it's technology and the industry as a whole - Identify important trends and provide sales forecasts by product categories ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.